Dergiler / Medicine Science / 2020 / Cilt: 9 - Sayı: 2

Evaluation of ultrasonographic thyroid imaging reporting and data system and color doppler imaging findings in thyroid nodules

Sayfa
343–346
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CDI findings are not guiding to decide for FNAB.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The prevalence of thyroid nodules is high, and the most commonly used imaging modality is ultrasonography (US).
📊
Temel Bulgular & Veri:A total of 83 patients admitted to our hospital between January 2018 and January 2019 were included in this study retrospectively.
💡
Sonuç & Katkı:CDI findings are not guiding to decide for FNAB.
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

The prevalence of thyroid nodules is high, and the most commonly used imaging modality is ultrasonography (US). Fine needle aspiration biopsy (FNAB) is performed for suspicious nodules after US evaluation, and a guideline called Thyroid Imaging Reporting and Data System (TIRADS) is available to make a biopsy decision. Our study aimed to evaluate TIRADS and Color Doppler Imaging (CDI) findings in nodules together with FNAB results. A total of 83 patients admitted to our hospital between January 2018 and January 2019 were included in this study retrospectively. B-mode US and CDI findings of the nodules, histopathological analysis results were recorded. Diagnostic efficacy of TIRADS classification and CDI findings were evaluated statistically. In our study, 70 (84.34%) of the nodules were found to be benign and 13 (15.66%) were found to be malignant. There was no difference between the benign and malignant groups in the evaluation of blood supply types using CDI (p>0.05). According to B mod US, 6 (27.3%) of 22 lesions with TIRADS 5, 5 (17.9%) of 28 lesions with TIRADS 4 and 2 (6.1%) of 33 lesions with TIRADS 3 were diagnosed as malignant. There was no statistically significant relationship between TIRADS categories and blood supply types in malignant lesions (p> 0.05). CDI examination of thyroid nodules did not reveal any blood supply patterns that could be significant for malignancy. CDI findings are not guiding to decide for FNAB.

🔖

Bu Makaleye Atıf Yap

UMAY, S., URFALI, F., KORKMAZ, M. E. (2020). Evaluation of ultrasonographic thyroid imaging reporting and data system and color doppler imaging findings in thyroid nodules. Medicine Science, Cilt: 9 - Sayı: 2, 343–346. https://ajindex.com/articles/276881

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Fagin JA, Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab. 2008;22:955 –69
  2. Tessler FN, Middleton WD, Grant EG. Thyroid Imaging Reporting and Data System (TI-RADS): A User’s Guide. Radiology. 2018;287:29-36
  3. Phuttharak W, Somboonporn C, Hongdomnern G. Diagnostic performance of gray-scale versus combined gray-scale with color doppler ultrasonography in the diagnosis of malignancy in thyroid nodules. Asian Pac J Cancer Prev. 2009;10:759-64
  4. Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): whitepaper of the ACR TI-RADS Committee. J Am CollRadiol. 2017;14:587–95
  5. Grace JD, Kasala R, Yao C, OngocoR, Mojica DJ. Thyroid Imaging Reporting and Data System (TIRADS) in Stratifying Risk of Thyroid Malignancy at The Medical City. JAFES. 2017;32:108-16
  6. Phuttharak W, Boonrod A, Klungboonkrong V, et al. Interrater reliability of various thyroid imaging reporting and data system (TIRADS) classifications for differentiating benign from malignant thyroid nodules. Asian Pac J Cancer Prev. 2019;29;20:1283-8
  7. Chng CL, Tan HC, Too CW, et al. Diagnostic performance of ATA, BTA, and TIRADS sonographic patterns in the prediction of malignancy in histologically proven thyroid nodules. Singapore Med J. 2018;59:578-83
  8. Ha SM, Baek JH, Choi YJ, et al. Malignancy risk of initially benign thyroid nodules: validation with various Thyroid Imaging Reporting and Data System guidelines. Eur Radiol. 2019;29:133-40
  9. Sahli ZT, Karipineni F, Hang JF, et al. The association between the ultrasonography TIRADS classification system and surgical pathology among indeterminate thyroid nodules. Surgery. 2019;165:69-74
  10. Cavallo A, Johnson DN, White MG, et al. Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size. Thyroid. 2017;27:641- 50
  11. Fradin JM. ACR TI-RADS: An advance in the management of thyroid nodules or Pandora’s box of surveillance? J Clin Ultrasound. 2019 Aug 16
  12. Darvish L, Khezri M, Teshnizi SH, et al. Color Doppler ultrasonography diagnostic value in the detection of malignant nodules in cysts with pathologically proven thyroid malignancy: a systematic review and metaanalysis. Clin Transl Oncol. 2019;21:1712-29
  13. Moon HJ, Kwak JY, Kim MJ, et al. Can vascularity at power Doppler US help predict thyroid malignancy? Radiology. 2010; 255:260-9
  14. Zhu YC, Zhang Y, Deng SH, Jiang Q. A Prosp